AbCellera Biologics (ABCL) Shares Outstanding (Diluted) (2020 - 2026)

AbCellera Biologics (ABCL) Shares Outstanding (Diluted) (2020 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Dil.) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 255.20 Mn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 106.00 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 64.41 Mn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 210.89 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 1.51 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 25.05 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn - 556.90 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 138.28 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 217.35 Mn
10 AbCellera Biologics 3.49 Bn 3.49 Bn - 305.56 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 305.56 Mn
Mar 31, 2026 303.07 Mn
Dec 31, 2025 298.71 Mn
Sep 30, 2025 298.88 Mn
Jun 30, 2025 298.51 Mn
Mar 31, 2025 297.69 Mn
Dec 31, 2024 294.33 Mn
Sep 30, 2024 294.85 Mn
Jun 30, 2024 294.22 Mn
Mar 31, 2024 292.72 Mn
Dec 31, 2023 289.17 Mn
Sep 30, 2023 289.50 Mn
Jun 30, 2023 288.91 Mn
Mar 31, 2023 287.77 Mn
Dec 31, 2022 314.83 Mn
Sep 30, 2022 315.82 Mn
Jun 30, 2022 284.69 Mn
Mar 31, 2022 311.48 Mn
Dec 31, 2021 318.29 Mn
Sep 30, 2021 278.93 Mn